Radiolabelled tracers and anticancer drugs for assessment of therapeutic efficacy using PET.

scientific article

Radiolabelled tracers and anticancer drugs for assessment of therapeutic efficacy using PET. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.2174/1381612013396907
P698PubMed publication ID11772355

P2093author name stringBrown GD
Saleem A
Price PM
Osman S
Brady F
Luthra SK
Aboagye E
P433issue18
P304page(s)1863-1892
P577publication date2001-12-01
P1433published inCurrent Pharmaceutical DesignQ5195068
P1476titleRadiolabelled tracers and anticancer drugs for assessment of therapeutic efficacy using PET.
P478volume7

Reverse relations

cites work (P2860)
Q33848618A Multifunctional Nanocrystalline CaF2:Tm,Yb@mSiO2 System for Dual-Triggered and Optically Monitored Doxorubicin Delivery.
Q51487132Fluorine-18 radiolabeling of a nitrophenyl sulfoxide and its evaluation in an SK-RC-52 model of tumor hypoxia.
Q35041962Functional imaging for assessment of therapy
Q35058563Molecular imaging in drug discovery and development
Q36197970Molecular imaging probe development: a chemistry perspective.
Q34974991PET for in vivo pharmacokinetic and pharmacodynamic measurements
Q90618474Preclinical Molecular Imaging for Precision Medicine in Breast Cancer Mouse Models
Q51745984Real-time in vivo quantitative monitoring of drug release by dual-mode magnetic resonance and upconverted luminescence imaging.
Q35777197The role of positron emission tomography in the discovery and development of new drugs; as studied in laboratory animals
Q34067838What does positron emission tomography offer oncology?

Search more.